[Medigate News Reporter Seo Min-ji] Although the number of patients with degenerative arthritis increases worldwide every year due to the aging of the population, there are still only painkillers for pain relief and no fundamental treatment, so the unmet medical need is very high.
According to the biopharmaceutical industry on the 27th, many companies are continuing their research on advanced regenerative biopharmaceuticals such as stem cells in order to solve unmet demand.
Exostemtech CEO Cho Yong-woo (Professor Erica Materials Engineering, Hanyang University) introduced the process of developing an exosome-based degenerative arthritis treatment at the recently held 2022 Advanced Regenerative Medical Education Forum.